ALLEGRO MICROSYSTEMS, INC.
For the period ended Mar 27, 2026. Filed May 21, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2026 · Filed May 21, 2026
ALGM$30.70-0.7%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 8. Consolidated Statements of Cash Flows
| Fiscal Year Ended | |||
|---|---|---|---|
| March 27,2026 | March 28,2025 | March 29,2024 | |
| Cash flows from operating activities: | |||
| Net (loss) income | $(14,653) | $(72,763) | $152,888 |
| Adjustments to reconcile net (loss) income to net cash provided by operating activities: | |||
| Depreciation and amortization | 67,593 | 64,502 | 71,382 |
| Amortization of deferred financing costs | 2,245 | 2,513 | 527 |
| Deferred income taxes | (11,994) | (16,301) | (18,613) |
| Stock-based compensation | 47,910 | 41,868 | 42,457 |
| Loss on change in fair value of forward repurchase contract | — | 34,752 | — |
| Impairment of assets held for sale | 6,590 | — | — |
| Impairment of long-lived assets | — | — | 13,218 |
| Provisions for inventory and expected credit losses | 10,011 | 9,216 | 10,286 |
| Change in fair value of marketable securities | — | — | 3,579 |
| Other non-cash reconciling items | 653 | 6,984 | 70 |
| Changes in operating assets and liabilities: | |||
| Trade accounts receivable | (9,201) | 33,081 | (7,964) |
| Accounts receivable - other | (9,805) | 155 | (1,035) |
| Inventories | (6,267) | (30,160) | (15,848) |
| Payment to related party | (15,000) | — | — |
| Prepaid expenses and other assets | 49,417 | (4,756) | (40,231) |
| Trade accounts payable | 5,996 | 4,044 | (12,653) |
| Due to and from related party | (1,740) | 5,115 | 5,231 |
| Other changes in operating assets and liabilities, net | 41,314 | (16,337) | (21,579) |
| Net cash provided by operating activities | 163,069 | 61,913 | 181,715 |
| Cash flows from investing activities: | |||
| Purchases of property, plant and equipment | (38,176) | (39,955) | (124,772) |
| Purchases of intangible assets | — | (1,180) | — |
| Acquisition of business, net of cash acquired and working capital adjustment | — | 319 | (408,119) |
| Investment in debt security | (3,541) | — | — |
| Sales in marketable securities | — | — | 16,175 |
| Net cash used in investing activities | (41,717) | (40,816) | (516,716) |
| Cash flows from financing activities: | |||
| Borrowings of 2023 term loan facility, net of deferred financing costs | — | — | 245,452 |
| Repayment of 2020 term loan facility | — | — | (25,000) |
| Net proceeds from 2026 Refinanced Term Loan Facility | 285,000 | 193,081 | — |
| Repayment of term loan | (345,000) | (105,000) | (625) |
| Repayments of other debt | — | — | (842) |
| Finance lease payments | (1,368) | (1,201) | (142) |
| Receipts on related party notes receivable | — | 1,875 | 3,750 |
| Payments for intangible assets | (5,000) | — | — |
| Payments for taxes related to net share settlement of equity awards | (12,612) | (16,238) | (25,900) |
| Proceeds from issuance of common stock under employee purchase plan | 3,337 | 3,511 | 3,635 |
| Repurchases of common stock | — | (853,921) | — |
| Net proceeds from issuance of common stock | — | 665,850 | — |
| Payments for taxes related to repurchase of common stock | (1,713) | — | — |
| Dividends paid to non-controlling interest | (23) | (19) | — |
| Payments of debt issuance costs | — | — | (1,450) |
| Net cash (used in) provided by financing activities | (77,379) | (112,062) | 198,878 |
| Effect of exchange rate changes on cash and cash equivalents and restricted cash | 277 | (89) | (421) |
| Net increase (decrease) in cash and cash equivalents and restricted cash | 44,250 | (91,054) | (136,544) |
| Cash and cash equivalents and restricted cash at beginning of period | 131,107 | 222,161 | 358,705 |
| Cash and cash equivalents and restricted cash at end of period: | $175,357 | $131,107 | $222,161 |
| Reconciliation of cash and cash equivalents and restricted cash: | |||
| Cash and cash equivalents at beginning of period | $121,334 | $212,143 | $351,576 |
| Restricted cash at beginning of period | 9,773 | 10,018 | 7,129 |
| Cash and cash equivalents and restricted cash at beginning of period | $131,107 | $222,161 | $358,705 |
| Cash and cash equivalents at end of period | 168,753 | 121,334 | 212,143 |
| Restricted cash at end of period | 6,604 | 9,773 | 10,018 |
| Cash and cash equivalents and restricted cash at end of period | $175,357 | $131,107 | $222,161 |
| Fiscal Year Ended | |||
|---|---|---|---|
| March 27,2026 | March 28,2025 | March 29,2024 | |
| Supplemental disclosures of cash flow information: | |||
| Cash paid for interest | $19,375 | $21,959 | $10,153 |
| Cash (received) paid for income taxes, net of refunds | $(27,081) | $11,639 | $89,927 |
| Non-cash transactions: | |||
| Property, plant and equipment purchases included in trade accounts payable and accrued expenses | $(3,961) | $(4,463) | $(4,157) |
| Right-of-use assets obtained in exchange for lease liabilities | $1,584 | $6,999 | $10,450 |
| Assets held for sale transferred (to) from property, plant and equipment, net | $(9,751) | $16,508 | $— |
Notes to Consolidated Financial Statements
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.